Organization

Strand Therapeutics

1 clinical trial

Clinical trial

Ph 1/2 Open-label, Multi-center, FIH Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics & Antitumor Activity of STX-001 Via Intratumoral Injection in Pts w Advanced Solid Tumors as Monotherapy or Combination w Pembrolizumab

Status: Recruiting, Estimated PCD: 2027-05-01